Trillium Therapeutics Inc. SC 13D and SC 13D/A reports

Location
2488 Dunwin Drive, Mississauga, Ontario, Canada
State of incorporation
British Columbia, Canada
Fiscal year end
December 31
Data updated at
7/19/2024, 08:55 AM
Form type Sec Links Description Filing date Reporting date
SC 13D/A Report GROWTH EQUITY OPPORTUNITIES FUND V, LLC - TRILLIUM THERAPEUTICS -- SCHEDULE 13D/ Nov 19, 2021
SC 13D/A Report GROWTH EQUITY OPPORTUNITIES FUND V, LLC - TRILLIUM THERAPEUTICS -- SCHEDULE 13D/ Sep 1, 2021
SC 13D/A Report GROWTH EQUITY OPPORTUNITIES FUND V, LLC - TRILLIUM THERAPEUTICS INC. -- SCHEDULE Feb 4, 2020
SC 13D/A Report GROWTH EQUITY OPPORTUNITIES FUND V, LLC - TRILLIUM THERAPEUTICS INC. 13DA(#2) Mar 4, 2019
SC 13D/A Report GROWTH EQUITY OPPORTUNITIES FUND V, LLC - TRILLIUM 13DA-1 Dec 5, 2017
SC 13D Report GROWTH EQUITY OPPORTUNITIES FUND V, LLC - TRILLIUM 13D Jun 9, 2017